Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA

NCT: NCT05501236 · RECRUITING

NCT IDNCT05501236
StatusRECRUITING
Start Date2022-11-03
Completion2027-11-30
SponsorVanderbilt University Medical Center (OTHER)
First posted
Last updated

Brief Summary

Polysomnography (PSG) and drug-induced sleep endoscopy (DISE) are widely used diagnostic studies for assessing obstructive sleep apnea (OSA) severity and collapse patterns of the upper airway anatomy during sleep. Hypoglossal nerve stimulation (HNS) therapy for obstructive sleep apnea suffers from variable response at the level of the soft palate. The Investigators propose a study examining the physiologic effect of ansa cervicalis stimulation (ACS) alone and in combination with HNS during PSG and DISE.

Frequently Asked Questions

What is Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA?

Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA is a clinical trial registered under NCT05501236. Current status: RECRUITING.

What is the status of NCT05501236?

The current status of NCT05501236 (Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA) is: RECRUITING.

When did Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA start?

Ansa Cervicalis and Hypoglossal Nerve Stimulation in OSA started on 2022-11-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑